Study Evaluating a Heated Lidocaine and Tetracaine Topical Patch in the Treatment of Patients With Patellar Tendinopathy

• Status: Completed
• Trial end date: 2011-05-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of the study is to explore the potential usefulness of a heated lidocaine 70 mg and tetracaine 70 mg topical patch for the treatment of pain associated with patellar tendinopathy.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: ZARS Pharma Inc.
• Treatments: Lidocaine; Tetracaine

Criteria

Inclusion Criteria:

• be at least 18 years of age

• have pain associated with patellar tendinopathy in a single knee (minimum 2-week duration)

• have tenderness at the proximal insertion of the patellar tendon in the affected knee

Exclusion Criteria:

• have any history of surgery in the target knee

• have used any topically applied pain medication on the target treatment area within 3 days preceding the Screening/Baseline Visit

• have had any injected steroids in the target knee within 3 months of the Screening/Baseline Visit

• have used any injected pain medication within 14 days preceding the Screening/Baseline Visit

• are receiving class 1 antiarrhythmic drugs (ie, tocainide, mexiletine, etc.)

Other protocol-defined inclusion/exclusion criteria may apply.